Treatment with lenalidomide in myelodysplastic syndromes with deletion 5q: results from the Dutch named patient program

I. Abouyahya; C. Alhan; T.M. Westers; P.A. te Boekhorst; MC Kappers-Klunne; J.L. Coenen; F.H. Heyning; G.A. Huls; JT de Wolf; A.L. Imholz; H.R. Koene; G. Veth; E.J.F.M. de Kruijf; P. Muus; E.V. Planken; C.M. Segeren; W.L. Vasmel; A.M. van der Velden; G.A. Velders; J. Koedam; G.J. Ossenkoppele; A.A. van de Loosdrecht

doi:https://doi.org/10.3109/10428194.2012.728702

Treatment with lenalidomide in myelodysplastic syndromes with deletion 5q: results from the Dutch named patient program

I. Abouyahya, C. Alhan, T.M. Westers, P.A. te Boekhorst, MC Kappers-Klunne, J.L. Coenen, F.H. Heyning, G.A. Huls, JT de Wolf, A.L. Imholz, H.R. Koene, G. Veth, E.J.F.M. de Kruijf, P. Muus, E.V. Planken, C.M. Segeren, W.L. Vasmel, A.M. van der Velden, G.A. Velders, J. KoedamG.J. Ossenkoppele, A.A. van de Loosdrecht

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	874-877
Journal	Leukemia and Lymphoma
Volume	54
Issue number	4
DOIs	https://doi.org/10.3109/10428194.2012.728702
Publication status	Published - 2013

Access to Document

https://doi.org/10.3109/10428194.2012.728702

Cite this

Abouyahya, I., Alhan, C., Westers, T. M., te Boekhorst, P. A., Kappers-Klunne, MC., Coenen, J. L., Heyning, F. H., Huls, G. A., de Wolf, JT., Imholz, A. L., Koene, H. R., Veth, G., de Kruijf, E. J. F. M., Muus, P., Planken, E. V., Segeren, C. M., Vasmel, W. L., van der Velden, A. M., Velders, G. A., ... van de Loosdrecht, A. A. (2013). Treatment with lenalidomide in myelodysplastic syndromes with deletion 5q: results from the Dutch named patient program. Leukemia and Lymphoma, 54(4), 874-877. https://doi.org/10.3109/10428194.2012.728702

@article{f5d060f996ba412cad36bd9c44f84b94,

title = "Treatment with lenalidomide in myelodysplastic syndromes with deletion 5q: results from the Dutch named patient program",

author = "I. Abouyahya and C. Alhan and T.M. Westers and {te Boekhorst}, P.A. and MC Kappers-Klunne and J.L. Coenen and F.H. Heyning and G.A. Huls and {de Wolf}, JT and A.L. Imholz and H.R. Koene and G. Veth and {de Kruijf}, E.J.F.M. and P. Muus and E.V. Planken and C.M. Segeren and W.L. Vasmel and {van der Velden}, A.M. and G.A. Velders and J. Koedam and G.J. Ossenkoppele and {van de Loosdrecht}, A.A.",

year = "2013",

doi = "https://doi.org/10.3109/10428194.2012.728702",

language = "Undefined/Unknown",

volume = "54",

pages = "874--877",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "4",

}

Abouyahya, I, Alhan, C, Westers, TM, te Boekhorst, PA, Kappers-Klunne, MC, Coenen, JL, Heyning, FH, Huls, GA, de Wolf, JT, Imholz, AL, Koene, HR, Veth, G, de Kruijf, EJFM, Muus, P, Planken, EV, Segeren, CM, Vasmel, WL, van der Velden, AM, Velders, GA, Koedam, J, Ossenkoppele, GJ & van de Loosdrecht, AA 2013, 'Treatment with lenalidomide in myelodysplastic syndromes with deletion 5q: results from the Dutch named patient program', Leukemia and Lymphoma, vol. 54, no. 4, pp. 874-877. https://doi.org/10.3109/10428194.2012.728702

TY - JOUR

T1 - Treatment with lenalidomide in myelodysplastic syndromes with deletion 5q: results from the Dutch named patient program

AU - Abouyahya, I.

AU - Alhan, C.

AU - Westers, T.M.

AU - te Boekhorst, P.A.

AU - Kappers-Klunne, MC

AU - Coenen, J.L.

AU - Heyning, F.H.

AU - Huls, G.A.

AU - de Wolf, JT

AU - Imholz, A.L.

AU - Koene, H.R.

AU - Veth, G.

AU - de Kruijf, E.J.F.M.

AU - Muus, P.

AU - Planken, E.V.

AU - Segeren, C.M.

AU - Vasmel, W.L.

AU - van der Velden, A.M.

AU - Velders, G.A.

AU - Koedam, J.

AU - Ossenkoppele, G.J.

AU - van de Loosdrecht, A.A.

PY - 2013

Y1 - 2013

U2 - https://doi.org/10.3109/10428194.2012.728702

DO - https://doi.org/10.3109/10428194.2012.728702

M3 - Article

C2 - 22971215

SN - 1042-8194

VL - 54

SP - 874

EP - 877

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 4

ER -